Oramed Pharmaceuticals signed an agreement with OnQ consulting, a Johannesburg-based contract research organization (CRO), to conduct Phase IIB trials on its oral insulin capsules. The 30 subjects will each receive the treatment for a period of 6 weeks. Here is the news release.

Paradigm Management Services, a provider of catastrophic and complex medical management services, chose three new board members. Roger Jenkins has joined the board and the compensation committee. Jay Himmelstein joined the board and is the chair of the medical outcomes and quality assurance committee. Frederick Hudson joined the board and is chair of the audit committee. Here’s more information.

PPD has received the CEO Cancer Gold Standard accreditation from the CEO Roundtable on Cancer, recognizing the company’s efforts to reduce cancer risks among employees and improve their overall health.

Next Tuesday, on April 22, there is a webinar about the intersection of adaptive trials and electronic data capture (EDC) sponsored by TrialStat. Dennis King, president of StatKing Consulting, will be one presenter. “I’ve seen a lot of companies that don’t think about how to manage the data until it gets close to the end of the trial,” says another presenter, Therese Heinonen, associate director, medical affairs, Montreal Heart Institute. “You have to look at the overall development of a project and then take action.” The editor of ClinPage will be introducing the speakers and moderating the Q&A after their online presentations. Here’s a link for more information.

Merck Serono and its U.S. division EMD Serono, both part of Merck KGaA, announced an expansion of their American presence with an investment of $50 million at their Billerica facility, northwest of Boston. The company anticipates the investment will create more than 100 new jobs. Here’s the press release.

i3 acquired the Russian contract research organization Lege Artis. The addition of Moscow-based Lege Artis will provide i3 customers enhanced access to investigators in Russia and the neighboring states of the former Soviet Union. Lege Artis founder and CEO Tatjana Zwereva will lead the new Russian effort for i3, supported by a management team that includes Alexander Makarkov, a co-founder of her firm. Here’s the press release.

Have a news release? Send it to .